The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
was a trial that demonstrated that you could do stenting of coronary arteries safely with the addition of this drug that's no longer used because it had toxicity called ticlopidine, ticlid. [...] if you gave people this drug, Ticlan, at the time they got their stent, the chance of the stent clotting off went to almost zero.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.